<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572309</url>
  </required_header>
  <id_info>
    <org_study_id>CT0022018</org_study_id>
    <nct_id>NCT03572309</nct_id>
  </id_info>
  <brief_title>Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen</brief_title>
  <acronym>TICAF</acronym>
  <official_title>Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masaryk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Masaryk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to find out the incidence of trauma induced coagulopathy in
      patients with severe trauma who received fibrinogen prior admission to emergency department
      during prehospital care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will commence following the Approval by The Ethics Research Committee. All patients
      admitted to emergency department from the 1st of July 2018 to the 30st of June 2020 will be
      enrolled after fulfilling the inclusion criteria and in the absence of any exclusion
      criteria. Informed consent will be requested. After admission to emergency department the
      blood samples will be taken and blood tests and viscoelastic tests will be performed. All
      data and results will be entered in the study form. Statistical analysis will be performed
      and incidence of trauma induced coagulopathy estimated. 28-day mortality will be also
      monitored.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Trauma induced coagulopathy</measure>
    <time_frame>day of enrolment</time_frame>
    <description>Incidence of trauma induced coagulopathy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28day mortality</measure>
    <time_frame>28 days after enrolment</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Trauma</condition>
  <condition>Hemorrhage</condition>
  <condition>Coagulopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult trauma patients with severe trauma admitted to emergency departement of university
        hospital who recieved fibrinogen during prehospital care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  multiple trauma, injury severity score (ISS) â‰¥16

          -  administration of fibrinogen in prehospital care

          -  age 18-80 years

        Exclusion Criteria:

          -  ISS 75

          -  pregnancy

          -  therapeutic anticoagulation

          -  therapeutic antiaggregation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roman Gal, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Masaryk University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamil Vrbica, MD</last_name>
    <phone>+420532233850</phone>
    <email>Vrbica.Kamil@fnbrno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ondrej Hrdy, MD</last_name>
    <phone>+420532233850</phone>
    <email>Hrdy.Ondrej@fnbrno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Brno and Masaryk University Brno</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamil Vrbica, M.D.</last_name>
      <phone>532233850</phone>
      <phone_ext>+420</phone_ext>
      <email>vrbica.kamil@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Ondrej Hrdy, M.D.</last_name>
      <phone>532232305</phone>
      <phone_ext>+420</phone_ext>
      <email>hrdy.ondrej@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trauma induced coagulopathy</keyword>
  <keyword>multiple trauma</keyword>
  <keyword>fibrinogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

